Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Sarno

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Signal Transduction and Targeted Therapy|May 17, 2021
Protein kinase CK2: a potential therapeutic target for diverse human diseasesChristian Borgo, Claudio D'Amore, Stefania Sarno, et al.
Functional Neurology|June 1, 2006
Electrophysiological correlates of active and passive attentional states after severe traumatic brain injuryStefania Sarno, Lutz-Peter Erasmus, Marcel Frey, et al.
Biochimica Et Biophysica Acta|April 3, 2009
Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysisMauro Salvi, Stefania Sarno, Luca Cesaro, et al.
Biochimica Et Biophysica Acta|October 4, 2005
Features and potentials of ATP-site directed CK2 inhibitorsStefania Sarno, Mauro Salvi, Roberto Battistutta, et al.
Annals of Human Biology|November 30, 2017
Ripples on the surface. Surnames and genes in Sicily and Southern ItalyAlessio Boattini, Stefania Sarno, Ornella Fiorani, et al.
Biochemical and Biophysical Research Communications|January 18, 2012
Superiority of PLK-2 as α-synuclein phosphorylating agent relies on unique specificity determinantsMauro Salvi, Edlir Trashi, Oriano Marin, et al.
Communications Biology|June 23, 2026
Adaptive evolution at thyroid hormone, insulin and glycerolipid pathways improved energy metabolism in high-latitude Eurasian populationsGiulia Ferraretti, Marta Alberti, Rosita Cicolini, et al.
Chemistry & Biology|November 22, 2005
Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazoleRoberto Battistutta, Marco Mazzorana, Stefania Sarno, et al.
FEBS Letters|June 30, 2006
Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunitsMauro Salvi, Stefania Sarno, Oriano Marin, et al.
Biochemical and Biophysical Research Communications|July 21, 2009
Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cellsMauro Salvi, Dong Xu, Yingyu Chen, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Signal Transduction and Targeted Therapy|May 17, 2021
Protein kinase CK2: a potential therapeutic target for diverse human diseasesChristian Borgo, Claudio D'Amore, Stefania Sarno, et al.
Functional Neurology|June 1, 2006
Electrophysiological correlates of active and passive attentional states after severe traumatic brain injuryStefania Sarno, Lutz-Peter Erasmus, Marcel Frey, et al.
Biochimica Et Biophysica Acta|April 3, 2009
Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysisMauro Salvi, Stefania Sarno, Luca Cesaro, et al.
Biochimica Et Biophysica Acta|October 4, 2005
Features and potentials of ATP-site directed CK2 inhibitorsStefania Sarno, Mauro Salvi, Roberto Battistutta, et al.
Annals of Human Biology|November 30, 2017
Ripples on the surface. Surnames and genes in Sicily and Southern ItalyAlessio Boattini, Stefania Sarno, Ornella Fiorani, et al.
Biochemical and Biophysical Research Communications|January 18, 2012
Superiority of PLK-2 as α-synuclein phosphorylating agent relies on unique specificity determinantsMauro Salvi, Edlir Trashi, Oriano Marin, et al.
Communications Biology|June 23, 2026
Adaptive evolution at thyroid hormone, insulin and glycerolipid pathways improved energy metabolism in high-latitude Eurasian populationsGiulia Ferraretti, Marta Alberti, Rosita Cicolini, et al.
Chemistry & Biology|November 22, 2005
Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazoleRoberto Battistutta, Marco Mazzorana, Stefania Sarno, et al.
FEBS Letters|June 30, 2006
Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunitsMauro Salvi, Stefania Sarno, Oriano Marin, et al.
Biochemical and Biophysical Research Communications|July 21, 2009
Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cellsMauro Salvi, Dong Xu, Yingyu Chen, et al.
Pageof 12